CardioComm Solutions Valuation
| EKGGF Stock | USD 0.01 0.00 0.00% |
CardioComm Solutions seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CardioComm Solutions from analyzing the firm fundamentals such as Return On Asset of 0.16, shares outstanding of 151.16 M, and Operating Margin of 0.08 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CardioComm Solutions' price fluctuation is out of control at this time. Calculation of the real value of CardioComm Solutions is based on 3 months time horizon. Increasing CardioComm Solutions' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CardioComm pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CardioComm Solutions. Since CardioComm Solutions is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CardioComm Pink Sheet. However, CardioComm Solutions' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.013 | Real 0.009744 | Hype 0.01 | Naive 0.0133 |
The real value of CardioComm Pink Sheet, also known as its intrinsic value, is the underlying worth of CardioComm Solutions Company, which is reflected in its stock price. It is based on CardioComm Solutions' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CardioComm Solutions' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CardioComm Solutions helps investors to forecast how CardioComm pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CardioComm Solutions more accurately as focusing exclusively on CardioComm Solutions' fundamentals will not take into account other important factors: CardioComm Solutions Total Value Analysis
CardioComm Solutions is currently forecasted to have takeover price of 1.82 M with market capitalization of 1.69 M, debt of 413.81 K, and cash on hands of 153.45 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CardioComm Solutions fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.82 M | 1.69 M | 413.81 K | 153.45 K |
CardioComm Solutions Investor Information
About 38.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. CardioComm Solutions had 1:5 split on the 26th of November 2007. Based on the key indicators related to CardioComm Solutions' liquidity, profitability, solvency, and operating efficiency, CardioComm Solutions is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.CardioComm Solutions Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CardioComm Solutions has an asset utilization ratio of 140.3 percent. This implies that the Company is making $1.4 for each dollar of assets. An increasing asset utilization means that CardioComm Solutions is more efficient with each dollar of assets it utilizes for everyday operations.CardioComm Solutions Ownership Allocation
CardioComm Solutions holds a total of 151.16 Million outstanding shares. CardioComm Solutions retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CardioComm Solutions Profitability Analysis
The company reported the revenue of 682.51 K. Net Income was 283 with profit before overhead, payroll, taxes, and interest of 734.6 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CardioComm Solutions' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CardioComm Solutions and how it compares across the competition.
About CardioComm Solutions Valuation
The pink sheet valuation mechanism determines CardioComm Solutions' current worth on a weekly basis. Our valuation model uses a comparative analysis of CardioComm Solutions. We calculate exposure to CardioComm Solutions's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CardioComm Solutions's related companies.CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange.
8 Steps to conduct CardioComm Solutions' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CardioComm Solutions' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CardioComm Solutions' valuation analysis, follow these 8 steps:- Gather financial information: Obtain CardioComm Solutions' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CardioComm Solutions' revenue streams: Identify CardioComm Solutions' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CardioComm Solutions' industry and market trends, including the size of the market, growth rate, and competition.
- Establish CardioComm Solutions' growth potential: Evaluate CardioComm Solutions' management, business model, and growth potential.
- Determine CardioComm Solutions' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CardioComm Solutions' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CardioComm Solutions Growth Indicators
Investing in growth stocks can be very risky. If the company such as CardioComm Solutions does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 150.3 M | |
| Quarterly Earnings Growth Y O Y | 2.303 | |
| Retained Earnings | -35.2 M |
Complementary Tools for CardioComm Pink Sheet analysis
When running CardioComm Solutions' price analysis, check to measure CardioComm Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioComm Solutions is operating at the current time. Most of CardioComm Solutions' value examination focuses on studying past and present price action to predict the probability of CardioComm Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioComm Solutions' price. Additionally, you may evaluate how the addition of CardioComm Solutions to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |